Bio-Rad Laboratories, Inc. (BIO) — QMA analysis
Sector: Healthcare · Market cap: $7.9B · Price: $369.95 · Data as of 2026-10-23
A composite score of 52/100 places Bio-Rad Laboratories, Inc. in the neutral band, higher score than 76% of 22,734 tracked stocks. The highest-scoring layer is Off-exchange trading (FINRA) / large flows; the lowest is Insider activity.
What 6 data layers say about BIO
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 66/100 |
| Technical trend (TSS) | 60/100 |
| Relative strength (RS) | 44/100 |
| Momentum (USS) | 45/100 |
| Insider activity (IAS) | 10/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 67/100 |
What does the QMA model currently show for Bio-Rad Laboratories, Inc.?
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
For BIO the layers diverge — some score high (Off-exchange trading (FINRA) / large flows), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
BIO insider & smart money activity
Over the recent period we record 0 reported insider purchases and 45 sales for BIO: only reported sales, no purchases. A description of the data layer, not an instruction.
BIO seasonality
The historically strong window for BIO was July 1–28 with a hit rate of 71% and an average move of 4.6% (21 years of history).
Historical data does not guarantee future results.
How BIO compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for BIO stock?
52/100 (grade C) as of 2026-10-23, fusing 6 data layers. An analytical score, not advice.
Are insiders buying BIO stock?
Over the recent period, reported: purchases 0, sales 45 (sales $5.02M). Insider activity: only reported sales, no purchases — a description of reported data, not a trade instruction.
Where can I see live BIO data?
Live BIO data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Explore more — for free
The BIO score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.
Want the full BIO analysis with all layers and live data? Open BIO detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]